On this page you'll find 10+ example sentences with Ionis. Discover how to use the word correctly in a sentence.
Using Ionis
- In the example corpus, ionis often appears in combinations such as: ionis pharmaceuticals, of ionis, in ionis.
Context around Ionis
- Average sentence length in these examples: 20.4 words
- Position in the sentence: 3 start, 17 middle, 0 end
- Sentence types: 20 statements, 0 questions, 0 exclamations
Corpus analysis for Ionis
- In this selection, "ionis" usually appears in the middle of the sentence. The average example has 20.4 words, and this corpus slice is mostly made up of statements.
- Around the word, january, lowered, now, pharmaceuticals and announced stand out and add context to how "ionis" is used.
- Recognizable usage signals include shares of ionis pharmaceuticals by and position in ionis pharmaceuticals by. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "ionis" sits close to words such as abadi, acidification and acker, which helps place it inside the broader word index.
Example types with ionis
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
Cantor Fitzgerald began coverage on Ionis Pharmaceuticals in a report on Tuesday, April 9th. (14 words)
Captrust Financial Advisors lifted its position in Ionis Pharmaceuticals by 21.1% in the second quarter. (16 words)
Creative Planning increased its holdings in shares of Ionis Pharmaceuticals by 9.1% in the 3rd quarter. (17 words)
In January, Ionis announced it had sold an interest in two of its medicines to Royalty Pharma for $500 million upfront and up to $625 million in additional payments based on future production. (33 words)
Allianz Asset Management GmbH lessened its stake in Ionis Pharmaceuticals, Inc. () by 99.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. (32 words)
For 30 years now Ionis has been the leading innovator in RNA-targeted therapeutics and I'm extremely confident that we'll continue to be the leader for the foreseeable future. (31 words)
Example sentences (20)
Allianz Asset Management GmbH lessened its stake in Ionis Pharmaceuticals, Inc. () by 99.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC.
Captrust Financial Advisors lifted its position in Ionis Pharmaceuticals by 21.1% in the second quarter.
Creative Planning increased its holdings in shares of Ionis Pharmaceuticals by 9.1% in the 3rd quarter.
Finally, First Trust Advisors LP boosted its holdings in Ionis Pharmaceuticals by 30.1% during the third quarter.
Finally, Seven Eight Capital LP lifted its holdings in shares of Ionis Pharmaceuticals by 13.2% during the 4th quarter.
In January, Ionis announced it had sold an interest in two of its medicines to Royalty Pharma for $500 million upfront and up to $625 million in additional payments based on future production.
PNC Financial Services Group Inc. grew its holdings in Ionis Pharmaceuticals by 9.4% during the 1st quarter.
Vanguard Group Inc. grew its holdings in shares of Ionis Pharmaceuticals by 5.0% during the third quarter.
Wipfli Financial Advisors LLC acquired a new position in shares of Ionis Pharmaceuticals during the 3rd quarter worth approximately $27,000.
Almanack Investment Partners LLC. purchased a new stake in Ionis Pharmaceuticals in the third quarter worth $44,000.
Finally, Horizon Investments LLC increased its position in Ionis Pharmaceuticals by 29.6% in the second quarter.
Quantbot Technologies LP purchased a new stake in Ionis Pharmaceuticals in the 2nd quarter valued at $44,000.
This table compares Aytu Bioscience and Ionis Pharmaceuticals’ net margins, return on equity and return on assets.
William Blair reaffirmed a hold rating on shares of Ionis Pharmaceuticals in a research report on Wednesday, August 5th.
Advisory Services Network LLC lifted its holdings in shares of Ionis Pharmaceuticals by 38.5% in the second quarter.
Also, Chairman Stanley T. Crooke sold 46,904 shares of Ionis Pharmaceuticals stock in a transaction that occurred on Wednesday, February 13th.
Cantor Fitzgerald began coverage on Ionis Pharmaceuticals in a report on Tuesday, April 9th.
DNB Asset Management AS lifted its position in Ionis Pharmaceuticals by 5.3% in the third quarter.
Finally, Zacks Investment Research lowered Ionis Pharmaceuticals from a “buy” rating to a “hold” rating in a report on Friday, April 5th.
For 30 years now Ionis has been the leading innovator in RNA-targeted therapeutics and I'm extremely confident that we'll continue to be the leader for the foreseeable future.
Common combinations with ionis
These word pairs occur most frequently in English texts:
- ionis pharmaceuticals 26×
- of ionis 11×
- in ionis 9×
- at ionis 2×
- ionis and 2×